KIF2C Facilitates Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with a poor prognosis. For PDAC, an increase in the survival time of patients and a reduction mortality have not yet successfully been achieved. In many research works, Kinesin family member 2C (KIF2C) is highly expressed in several t...
Main Authors: | Xing Huang, Feng Zhao, Quan Wu, Zitong Wang, Haiyue Ren, Qiqi Zhang, Zhe Wang, Jin Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/5/1502 |
Similar Items
-
KIF11 manipulates SREBP2‐dependent mevalonate cross talk to promote tumor progression in pancreatic ductal adenocarcinoma
by: Xiang Gu, et al.
Published: (2022-09-01) -
Effect of Adenomatous Polyposis Coli Loss on Tumorigenic Potential in Pancreatic Ductal Adenocarcinoma
by: Jennifer M. Cole, et al.
Published: (2019-09-01) -
KIF15 is involved in development and progression of Burkitt lymphoma
by: Zhao Wang, et al.
Published: (2021-05-01) -
Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma
by: Anna Klimaszewska-Wiśniewska, et al.
Published: (2021-06-01) -
Expression of KIF3A in Different Gastric Mucosal Lesions, Metastatic Lymph Nodes and Its Relationship with Metastasis and Prognosis of Gastric Adenocarcinoma
by: LI Haiyan, et al.
Published: (2018-12-01)